During the meeting, Gan Jianmin, chairman of Minkang, introduced the development history and corporate culture of Minkang to the leaders, as well as the achievements of Minkang in building a comprehensive service for diabetes.

When it comes to the core projects at the current stage, Chairman Gan Jianmin said: "As one of the company's important development strategies, the closed-loop artificial pancreas will provide the ultimate solution for the insulin application group. Since 2020, the R&D team has broken down a series of technical barriers such as long-acting reaction mold, biocompatibility film, microneedle stability, microneedle printing accuracy and blood sugar numerical algorithm, with the CGMs products as the starting point. Among them, the carbon monoatom catalytic technology has reached the international leading level. Next we will gradually carry out the relevant R&D works of dressing insulin pump and control algorithm. "

Subsequently, the leaders were introduced to Minkang 's new idea of diversified marketing in 2023, that is, to fully implement the multi-channel marketing pattern of agents+terminal pharmacies+hospitals+primary medical care, which will aim at the blank markets such as hospital surgery and outpatient service in the future. Gan Jianmin mentioned that in the medium and long term, the blood glucose management in the hospital may break the departmental barriers, and achieve unified management of multiple departments by virtue of the Internet of Things, the Internet, Cloud Computing, AI and other technologies. Minkang will achieve a breakthrough by virtue of its excellent integrated management and blood glucose management ecological engineering construction capabilities.

The leaders fully recognized the outstanding contribution made by Minkang in the field of chronic disease prevention and control by rapid detection products for chronic diseases using biosensor technology, and expressed their gratitude to Minkang for its continuous development in Tianjin, and highly praised Chairman Gan Jianmin, who firmly committed to innovation and development and deeply rooted in the field of blood sugar management.

Deputy director Li Hong conveyed some new policies of Tianjin on enterprise listing to Minkang, fully understood the historical financing situation and future planning of enterprises, and gave suggestions on some substantive issues.

The leaders exchanged business development, business scale and listing process arrangement with Chairman Gan Jianmin. From the perspective of listing standard selection, exchange audit focus, question answering method, financial data and other aspects, they purposely answered questions for Minkang, gave professional suggestions, and provided advanced and early services for enterprises to complete tax planning and shorten the listing cycle.